Magnetic nanoparticles: preparation methods, applications in cancer diagnosis and cancer therapy
Source abstract
Abstract
Super-paramagnetic iron oxide nanoparticles (SPIONs) have been widely explored as novel magnetic resonance imaging (MRI) contrast agents because of a combination of favorable super-paramagnetic properties, biodegradability, and surface properties. Among the numerous MNPs under examination, SPIONs have involved considerable interest due to their outstanding magnetic properties, biocompatibility, and biodegradability. This review debates the ABCs of MR imaging, reports and informs the state of the art of magnetic nanoparticles in cancer dealing the source of SPIONs' exclusive magnetic properties, recent progresses in MRI acquisition methods for detection of SPIONs.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Iron oxide chemistry and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Faculty of Medicine, Islamic Azad University Tabriz Branch, Tabriz, Iran;
Department of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran;
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran;
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
References (77)
Show source-provided references
1. 10.3109/21691401.2014.92788010.3109/21691401.2014.927880 ↗
2. Abbasi E · Crit Rev Microbiol · 2016
3. 10.1016/j.jmmm.2014.12.07710.1016/j.jmmm.2014.12.077 ↗
4. 10.1039/c2sm06872a10.1039/c2sm06872a ↗
5. 10.3109/21691401.2014.92877810.3109/21691401.2014.928778 ↗
6. 10.2147/IJN.S2834410.2147/IJN.S28344 ↗
7. 10.1166/jcsb.2014.108010.1166/jcsb.2014.1080 ↗
8. 10.2967/jnumed.108.05354610.2967/jnumed.108.053546 ↗
9. 10.1021/am302883m10.1021/am302883m ↗
10. Chang TMS. · Trans Am Soc Artif Intern Organs. · 1966 · 12 · 13
11. 10.3109/21691401.2014.94464410.3109/21691401.2014.944644 ↗
12. Clarkson R. 2002. Blood-pool MRI Contrast Agents: Properties and Characterization. Springer, pp. 2012–2035.10.1007/3-540-45733-X_7 ↗
13. 10.1097/01.rli.0000135980.08491.3310.1097/01.rli.0000135980.08491.33 ↗
14. Daraee H · Artif Cells Nanomed Biotechnol · 2016
15. Daraee H · Artif Cells Nanomed Biotechnol · 2016
16. 10.7314/APJCP.2014.15.10.435310.7314/APJCP.2014.15.10.4353 ↗
17. 10.1126/science.107719410.1126/science.1077194 ↗
18. 10.3109/21691401.2014.92256810.3109/21691401.2014.922568 ↗
19. 10.3109/21691401.2014.94464610.3109/21691401.2014.944646 ↗
20. 10.3109/21691401.2014.93445610.3109/21691401.2014.934456 ↗
21. 10.1038/nrc156610.1038/nrc1566 ↗
22. 10.1016/j.ijpharm.2013.03.02510.1016/j.ijpharm.2013.03.025 ↗
23. Gogola D, Štrbák O, Škrátek M, Frollo I. 2013. Contrast agents based on magnetic nanoparticles and its interaction with surrounding environment during contrast imaging. In: MEASUREMENT 2013, Proceedings of the 9th International Conference, Smolenice, Slovakia; pp. 299–302.
24. 10.1021/nn300456z10.1021/nn300456z ↗
25. 10.1002/adma.20100026010.1002/adma.201000260 ↗
26. 10.2174/1573413711309999008510.2174/15734137113099990085 ↗
27. 10.1039/C4NR03482A10.1039/C4NR03482A ↗
28. 10.1111/cbdd.1231810.1111/cbdd.12318 ↗
29. 10.1016/j.biomaterials.2009.09.00410.1016/j.biomaterials.2009.09.004 ↗
30. 10.1007/s00396-014-3357-y10.1007/s00396-014-3357-y ↗
31. 10.3390/ijms1104175910.3390/ijms11041759 ↗
32. 10.1021/ja036809410.1021/ja0368094 ↗
33. 10.1021/ja203340u10.1021/ja203340u ↗
34. 10.1007/s11095-014-1417-010.1007/s11095-014-1417-0 ↗
35. 10.1016/j.ijpharm.2015.07.05910.1016/j.ijpharm.2015.07.059 ↗
36. 10.1039/c2jm32086j10.1039/c2jm32086j ↗
37. 10.1016/j.cis.2013.06.00710.1016/j.cis.2013.06.007 ↗
38. Lauffer R · 1996
39. 10.1021/cr068445e10.1021/cr068445e ↗
40. 10.1021/nl301030810.1021/nl3010308 ↗
41. 10.1016/j.biomaterials.2013.07.07010.1016/j.biomaterials.2013.07.070 ↗
42. 10.1016/j.biomaterials.2014.01.01110.1016/j.biomaterials.2014.01.011 ↗
43. 10.1016/j.actbio.2015.01.00610.1016/j.actbio.2015.01.006 ↗
44. 10.1002/anie.20110152110.1002/anie.201101521 ↗
45. 10.1002/anie.20060286610.1002/anie.200602866 ↗
46. 10.1016/j.arabjc.2010.09.02710.1016/j.arabjc.2010.09.027 ↗
47. 10.1039/b712721a10.1039/b712721a ↗
48. 10.3109/21691401.2014.95363210.3109/21691401.2014.953632 ↗
49. 10.1016/j.biomaterials.2014.05.01010.1016/j.biomaterials.2014.05.010 ↗
50. 10.1016/j.biomaterials.2010.03.07010.1016/j.biomaterials.2010.03.070 ↗
51. 10.1039/b902394a10.1039/b902394a ↗
52. Sadat Tabatabaei Mirakabad F · Artif Cells Nanomed Biotechnol · 2016
53. 10.1007/s10856-014-5187-310.1007/s10856-014-5187-3 ↗
54. 10.2174/156802661466614011820355010.2174/1568026614666140118203550 ↗
55. 10.1007/s10856-014-5197-110.1007/s10856-014-5197-1 ↗
56. 10.1016/j.carbpol.2014.01.01210.1016/j.carbpol.2014.01.012 ↗
57. 10.1039/C4TB01708K10.1039/C4TB01708K ↗
58. 10.1016/j.jmmm.2011.10.01710.1016/j.jmmm.2011.10.017 ↗
59. 10.1016/j.msec.2013.03.02810.1016/j.msec.2013.03.028 ↗
60. 10.1016/j.jmmm.2014.06.02310.1016/j.jmmm.2014.06.023 ↗
61. 10.1016/j.drudis.2013.10.00510.1016/j.drudis.2013.10.005 ↗
62. 10.1016/j.jmmm.2015.04.01710.1016/j.jmmm.2015.04.017 ↗
63. 10.1016/S1369-7021(11)70163-810.1016/S1369-7021(11)70163-8 ↗
64. 10.1021/ja038085210.1021/ja0380852 ↗
65. 10.1016/j.addr.2008.03.01810.1016/j.addr.2008.03.018 ↗
66. Surendra MK · J Nanopart Res · 2014 · 16 · 1
67. 10.1201/b1176010.1201/b11760 ↗
68. 10.1201/b1540310.1201/b15403 ↗
69. 10.1021/nl102623x10.1021/nl102623x ↗
70. 10.1038/nature0396810.1038/nature03968 ↗
71. 10.1016/j.jmmm.2011.05.06010.1016/j.jmmm.2011.05.060 ↗
72. 10.1002/jmri.2086610.1002/jmri.20866 ↗
73. 10.1007/s11671-008-9174-910.1007/s11671-008-9174-9 ↗
74. 10.1021/ja046480210.1021/ja0464802 ↗
75. 10.1016/j.colsurfb.2012.10.04110.1016/j.colsurfb.2012.10.041 ↗
76. 10.1039/b820176e10.1039/b820176e ↗
77. 10.1088/1748-6041/1/4/00410.1088/1748-6041/1/4/004 ↗